Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CTSC | P53634 | 1/20 | 0.36 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.36 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28110893 | 0.80 | SLC1A3 (0.42) | SMN1; SMN2ALDH1A1ATML3MBTL1 | |
| SCHEMBL27475534 | 0.79 | PPARG (0.44) | HPGDSMN1; SMN2POLBMAPK1PPARG | |
| SCHEMBL28111448 | 0.78 | KIF11 (0.44) | SMN1; SMN2ALDH1A1KMT2ALMNA | |
| SCHEMBL15763932 | 0.77 | PPARG (0.53) | HPGDSMN1; SMN2POLBMAPK1PPARG | |
| SCHEMBL938151 | 0.76 | PPARG (0.40) | HPGDSMN1; SMN2PPARGALDH1A1ATM | |
| SCHEMBL4418520 | 0.75 | PPARG (0.44) | HPGDSMN1; SMN2POLBMAPK1PPARG | |
| SCHEMBL6584647 | 0.74 | PPARG (0.50) | HPGDSMN1; SMN2POLBMAPK1PPARG | |
| SCHEMBL2002076 | 0.74 | PPARG (0.50) | HPGDSMN1; SMN2POLBMAPK1PPARG | |
| SCHEMBL15454362 | 0.73 | HPGD (0.54) | HPGDSMN1; SMN2POLBMAPK1PPARG | |
| SCHEMBL15763991 | 0.72 | MEN1 (0.51) | HPGDSMN1; SMN2POLBMAPK1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4440531-B1 | KIT AND METHOD FOR TREATING SKIN | OREAL (FR) | 2026-01-21 | — | — | EP | claimed |
| EP-4440531-A1 | KIT AND METHOD FOR TREATING SKIN | L'OREAL (FR) | 2024-10-09 | — | — | EP | claimed |
| WO-2023101902-A1 | KIT AND METHOD FOR TREATING SKIN | L'OREAL (FR) | 2023-06-08 | — | — | WO | claimed |
| US-20230165777-A1 | KIT AND METHOD FOR TREATING SKIN | L'OREAL (FR) | 2023-06-01 | — | — | US | claimed |
| EP-1415644-B1 | Cosmetic process for smoothing out expression wrinkles by topical application of a perfume composition | OREAL (FR) | 2008-02-20 | — | — | EP | claimed |
| EP-4440531-B1 | KIT AND METHOD FOR TREATING SKIN | OREAL (FR) | 2026-01-21 | — | — | EP | disclosed |
| EP-4440531-A1 | KIT AND METHOD FOR TREATING SKIN | L'OREAL (FR) | 2024-10-09 | — | — | EP | disclosed |
| WO-2023101902-A1 | KIT AND METHOD FOR TREATING SKIN | L'OREAL (FR) | 2023-06-08 | — | — | WO | disclosed |
| US-20230165777-A1 | KIT AND METHOD FOR TREATING SKIN | L'OREAL (FR) | 2023-06-01 | — | — | US | disclosed |
| US-20230133445-A1 | COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF SKIN | L'OREAL (FR) | 2023-05-04 | — | — | US | disclosed |
| EP-3840724-A1 | COSMETIC COMPOSITIONS COMPRISING ACETYL TRIFLUOROMETHYLPHENYL VALYLGLYCINE | L'OREAL (FR) | 2021-06-30 | — | — | EP | disclosed |
| EP-3840724-A1 | COSMETIC COMPOSITIONS COMPRISING ACETYL TRIFLUOROMETHYLPHENYL VALYLGLYCINE | L'OREAL (FR) | 2021-06-30 | — | — | EP | disclosed |
| WO-2020041389-A1 | COSMETIC COMPOSITIONS COMPRISING ACETYL TRIFLUOROMETHYLPHENYL VALYLGLYCINE | L'OREAL (FR) | 2020-02-27 | — | — | WO | disclosed |
| WO-2020041389-A1 | COSMETIC COMPOSITIONS COMPRISING ACETYL TRIFLUOROMETHYLPHENYL VALYLGLYCINE | L'OREAL (FR) | 2020-02-27 | — | — | WO | disclosed |
| US-10449133-B1 | Cosmetic compositions comprising acetyl trifluoromethylphenyl valylglycine | L'OREAL (FR) | 2019-10-22 | — | — | US | disclosed |
| EP-3551161-A1 | NON-STICKY STABLE COMPOSITION | L'Oréal (FR) | 2019-10-16 | — | — | EP | disclosed |
| WO-2018105503-A1 | NON-STICKY STABLE COMPOSITION | L'OREAL (FR) | 2018-06-14 | — | — | WO | disclosed |
| EP-2717970-A2 | POLYETHYLENE GLYCOL-FREE COSMETIC OR DERMATOLOGICAL PREPARATIONS | Beiersdorf AG (DE) | 2014-04-16 | — | — | EP | disclosed |
| WO-2012167906-A2 | COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH IMPROVED RHEOLOGICAL PROPERTIES | BEIERSDORF AG (DE) | 2012-12-13 | — | — | WO | disclosed |
| WO-2012167905-A2 | POLYETHYLENE GLYCOL-FREE COSMETIC OR DERMATOLOGICAL PREPARATIONS | BEIERSDORF AG (DE) | 2012-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10449133-B1 | Cosmetic compositions comprising acetyl trifluoromethylphenyl valylglycine | SUCLG1, ACACB, VCL | HPGD 1098/4885SMN1; SMN2 4401/4885POLB 551/4885 |
| US-20230165777-A1 | KIT AND METHOD FOR TREATING SKIN | KIT, GK, GANC | HPGD 2411/4885SMN1; SMN2 3081/4885POLB 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.